# Aerobic exercise improved liver steatosis by modulating miR-34a-mediated PPARα/SIRT1-AMPK signaling pathway

**Authors:** Baoai Wu, Zhibin Zhang, Chong Xu, Jinfeng Zhao

PMC · DOI: 10.1371/journal.pone.0333872 · PLOS One · 2025-11-12

## TL;DR

Aerobic exercise reduces liver fat by changing miR-34a and related metabolic pathways in mice.

## Contribution

This study reveals a novel mechanism by which aerobic exercise reduces liver steatosis through miR-34a and PPARα/SIRT1-AMPK signaling.

## Key findings

- Aerobic exercise reduced liver steatosis in mice fed a high-fat diet.
- Exercise downregulated miR-34a and increased PPARα and SIRT1 expression.
- Exercise activated AMPK and improved expression of genes related to fatty acid metabolism.

## Abstract

MicroRNA-34a (miR-34a) was closely associated with liver steatosis. However, the link between changes in miR-34a and the progression of liver steatosis remained unclear. In the work, sixty mice were randomly and equally selected into six groups: normal control group (NC), normal exercise group (NE), high-fat diet group (HFD), high-fat diet plus exercise group (HFE), miR-34a overexpression group (OE), and miR-34a overexpression plus exercise group (OEE). Live morphology showed that treadmill exercise intervention for 8 weeks reduced high-fat diet-induced liver steatosis in mice. 8-week treadmill exercise directly decreased mir-34a expression of mice in HFD group, confirmed in OE group. More, treadmill exercise enhanced the expression of PPARα and SIRT1, thereby affecting the downstream hepatic steatosis-associated target genes, including CPT1(Carnitine palmitoyltransferase 1), CPT2(Carnitine palmitoyltransferase 2), SLC27A1(Solute carrier family 27 member 1), SLC27A4(Solute carrier family 27 member 4), in addition to activating the expression of the central metabolic sensor AMPK. Following aerobic exercise intervention, miR-34a was downregulated, thereby affecting the expression of genes associated with hepatic steatosis, and this mechanism was confirmed in miR-34a overexpression mice. This study contributed to our understanding of the pathogenesis of hepatic steatosis and may provide new therapeutic approaches.

## Linked entities

- **Genes:** MIR34A (microRNA 34a) [NCBI Gene 407040], PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465], SIRT1 (sirtuin 1) [NCBI Gene 23411], PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562], CPT1A (carnitine palmitoyltransferase 1A) [NCBI Gene 1374], CPT2 (carnitine palmitoyltransferase 2) [NCBI Gene 1376], SLC27A1 (solute carrier family 27 member 1) [NCBI Gene 376497], SLC27A4 (solute carrier family 27 member 4) [NCBI Gene 10999]
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Slc27a1 (solute carrier family 27 (fatty acid transporter), member 1) [NCBI Gene 26457] {aka FATP1, Fatp, Vlc27a1}, Slc27a4 (solute carrier family 27 (fatty acid transporter), member 4) [NCBI Gene 26569] {aka ACSVL4, FATP4}, Mir34a (microRNA 34a) [NCBI Gene 723848] {aka Mirn34a, mir-34a, mmu-mir-34a}, Sirt1 (sirtuin 1) [NCBI Gene 93759] {aka SIR2L1, Sir2, Sir2a, Sir2alpha}, Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 19013] {aka 4933429D07Rik, Nr1c1, PPAR-alpha, PPARalpha, Ppar}, Cpt2 (carnitine palmitoyltransferase 2) [NCBI Gene 12896] {aka CPTII}, Cpt1b (carnitine palmitoyltransferase 1b, muscle) [NCBI Gene 12895] {aka Cpt1, Cpt1-m, Cpti, Cpti-m, M-cpti}
- **Diseases:** hepatic steatosis (MESH:D005234)
- **Chemicals:** fat (MESH:D005223)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12611108/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12611108/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC12611108/full.md

---
Source: https://tomesphere.com/paper/PMC12611108